Do age, diabetes and left ventricular function affect the outcomes of ischemic mitral valve repair?

Loreta Jankauskiene1, Milda Svagzdiene1, Edmundas Sirvinskas1

  • 1Institute of Cardiology, Lithuanian University of Health Sciences, Kaunas, Lithuania ; Clinic of Cardiothoracic and Vascular Surgery, Lithuanian University of Health Sciences, Medical Academy Hospital, Kaunas, Lithuania.

Insights

Elderly age, diabetes mellitus, and low ejection fraction do not impact mortality after coronary artery bypass grafting with mitral valve repair. Diabetes mellitus, however, increases perioperative myocardial infarction risk.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Mitral Valve Repair

Background:

  • Older age, comorbidities like diabetes mellitus (DM), and impaired left ventricular function increase risks after coronary artery bypass grafting (CABG) and mitral valve (MV) repair for ischemic mitral regurgitation (MR).
  • Understanding the impact of these factors is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To evaluate the influence of age, DM, and left ventricular ejection fraction (LVEF) on early and late outcomes following CABG with MV repair.
  • To identify specific risk factors affecting postoperative complications and mortality.

Main Methods:

  • Retrospective analysis of 394 patients undergoing CABG and MV repair.
  • Patients were stratified by age, DM status, and LVEF.
  • Comparison of echocardiography data, complication rates (including sepsis, MI, stroke), and mortality between groups.

Main Results:

  • No significant differences in mortality or early postoperative outcomes were observed based on age, DM, or LVEF.
  • Patients with DM showed a higher rate of perioperative myocardial infarction (MI) compared to those without DM.
  • Reverse remodeling of the left ventricle was more pronounced in patients with lower LVEF, but DM impaired this process.

Conclusions:

  • Elderly age, concomitant DM, and reduced LVEF do not adversely affect early or late mortality after MV repair for ischemic MR in CABG patients.
  • Concomitant DM is associated with an increased risk of perioperative MI and impaired left ventricular reverse remodeling.
  • These findings suggest that while these factors may not influence mortality, specific complications like MI are more prevalent in diabetic patients.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
469
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
586
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.4K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
462
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
381
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.1K